These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 31168733

  • 1. Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.
    Roth AM, Kral AH, Mitchell A, Mukherjee R, Davidson P, Lankenau SE.
    J Urban Health; 2019 Jun; 96(3):341-352. PubMed ID: 31168733
    [Abstract] [Full Text] [Related]

  • 2. Predicting the impact of placing an overdose prevention site in Philadelphia: a mathematical modeling approach.
    Wares JR, Dong J, Gevertz JL, Radunskaya A, Viner K, Wiebe D, Solomon S.
    Harm Reduct J; 2021 Oct 30; 18(1):110. PubMed ID: 34717657
    [Abstract] [Full Text] [Related]

  • 3. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
    Park JN, Sherman SG, Rouhani S, Morales KB, McKenzie M, Allen ST, Marshall BDL, Green TC.
    J Urban Health; 2019 Jun 30; 96(3):353-366. PubMed ID: 31168735
    [Abstract] [Full Text] [Related]

  • 4. Acceptability of Overdose Prevention Sites in the Business Community in Baltimore, Maryland.
    Sherman SG, Rouhani S, White RH, Weicker N, Morris M, Schneider K, Park JN, Barry C.
    J Urban Health; 2022 Aug 30; 99(4):723-732. PubMed ID: 35610474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High willingness to use overdose prevention sites among suburban people who use drugs who do not inject.
    Schneider KE, Urquhart GJ, Rouhani S, Allen ST, Morris M, Sherman SG.
    Harm Reduct J; 2023 Sep 21; 20(1):138. PubMed ID: 37735447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Healthcare providers' knowledge and attitudes about overdose prevention sites in Colorado.
    Paz E, Mashhouri V, Payton ME, Schwartz BD, Linger RMA.
    Harm Reduct J; 2024 Aug 24; 21(1):155. PubMed ID: 39182085
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and Correlates of Syringe Disposal Box Use in a Philadelphia Neighborhood with High Levels of Public Drug Injection.
    Roth AM, Mitchell AK, Mukherjee R, Scheim AI, Ward KM, Lankenau SE.
    Subst Use Misuse; 2021 Aug 24; 56(5):668-673. PubMed ID: 33663334
    [Abstract] [Full Text] [Related]

  • 10. Overcoming stigma: Community support for overdose prevention sites.
    Grisamore SP, DeMatteo D.
    Int J Drug Policy; 2024 May 24; 127():104415. PubMed ID: 38593517
    [Abstract] [Full Text] [Related]

  • 11. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC, Boyd J, Mayer S, Collins A, Kerr T, McNeil R.
    Soc Sci Med; 2019 Mar 24; 225():60-68. PubMed ID: 30798157
    [Abstract] [Full Text] [Related]

  • 12. Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid-Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas - United States, 2015-2017.
    Lippold KM, Jones CM, Olsen EO, Giroir BP.
    MMWR Morb Mortal Wkly Rep; 2019 Nov 01; 68(43):967-973. PubMed ID: 31671083
    [Abstract] [Full Text] [Related]

  • 13. Neighborhood racial composition, social capital and black all-cause mortality in Philadelphia.
    Hutchinson RN, Putt MA, Dean LT, Long JA, Montagnet CA, Armstrong K.
    Soc Sci Med; 2009 May 01; 68(10):1859-65. PubMed ID: 19324485
    [Abstract] [Full Text] [Related]

  • 14. Social mixing and correlates of injection frequency among opioid use partnerships.
    Rowe C, Santos GM, Raymond HF, Coffin PO.
    Int J Drug Policy; 2017 Mar 01; 41():80-88. PubMed ID: 28113118
    [Abstract] [Full Text] [Related]

  • 15. Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic.
    Galarneau LR, Speed K, Taylor M, Hyshka E.
    Can J Public Health; 2023 Oct 01; 114(5):787-795. PubMed ID: 37462841
    [Abstract] [Full Text] [Related]

  • 16. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.
    Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG.
    Drug Alcohol Depend; 2019 Nov 01; 204():107547. PubMed ID: 31536877
    [Abstract] [Full Text] [Related]

  • 17. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.
    Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, Beckwith CG, Linas BP, Walley AY.
    Drug Alcohol Depend; 2019 Jul 01; 200():59-63. PubMed ID: 31100636
    [Abstract] [Full Text] [Related]

  • 18. Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services.
    Panagiotoglou D, Lim J.
    Int J Drug Policy; 2022 Dec 01; 110():103881. PubMed ID: 36274565
    [Abstract] [Full Text] [Related]

  • 19. "We just don't have the space for it": Geographies of survival and spatial triage in overdose prevention sites.
    Olding M, Boyd J, Kerr T, McNeil R.
    Health Place; 2023 Sep 01; 83():103067. PubMed ID: 37352615
    [Abstract] [Full Text] [Related]

  • 20. Evaluating oxygen monitoring and administration during overdose responses at a sanctioned overdose prevention site in San Francisco, California: A mixed-methods study.
    Suen LW, Wenger LD, Morris T, Majano V, Davidson PJ, Browne EN, Ray B, Megerian CE, Lambdin BH, Kral AH.
    Int J Drug Policy; 2023 Nov 01; 121():104165. PubMed ID: 37652815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.